Emerging Challenges in Ghana's HPV Vaccination Rollout: Trust, Consent, and Communication

ABSTRACT Background Ghana's national rollout of the human papillomavirus (HPV) vaccine marks a major milestone in cervical cancer prevention. However, early implementation experiences highlight emerging challenges that may undermine vaccine uptake and equitable access. Drawing on recent public health reports and peer‐reviewed studies, this commentary examines the sociocultural and communication factors shaping HPV vaccine acceptance in Ghana. Main Argument Despite high awareness of cervical cancer risk, persistent parental hesitancy, questions surrounding consent for minors, and misinformation about vaccine safety continue to constrain coverage. Structural issues, including uneven service delivery, inadequate stakeholder engagement, and the legacy of mistrust from prior immunization campaigns, further complicate implementation. Evidence from Ghana and other sub‐Saharan contexts suggests that successful HPV vaccine uptake depends not only on availability but also on transparent communication, trust in institutions, and culturally responsive messaging. Strengthening collaboration between the Ghana Health Service, community leaders, and faith‐based organizations could foster local ownership and address moral or informational concerns. Ultimately, sustaining Ghana's HPV vaccination initiative requires a comprehensive communication strategy that integrates scientific evidence with community values, ensuring informed consent and public confidence. Conclusion These lessons have broader implications for immunization programmes in low‐ and middle‐income settings, where public trust remains pivotal to achieving global vaccination goals.